Haemonetics to Present at Raymond James 46th Annual Institutional Investors Conference

Core Insights - Haemonetics Corporation will have its President and CEO, Chris Simon, participate in a fireside chat with investors at the Raymond James 46th Annual Institutional Investors Conference on March 4, 2025 [1] - The event will be accessible via a live webcast on Haemonetics' Investor Relations website, with a replay available for 90 days post-event [2] - Haemonetics is a global healthcare company focused on innovative medical products and solutions aimed at improving patient care and reducing healthcare costs, particularly in blood and plasma collection, surgical suites, and hospital transfusion services [3]